4//SEC Filing
Ruff Shamim 4
Accession 0001209191-23-018231
CIK 0001358762other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 5:23 PM ET
Size
16.4 KB
Accession
0001209191-23-018231
Insider Transaction Report
Form 4
Ruff Shamim
Director
Transactions
- Exercise/Conversion
Class A common stock
2023-03-10$34.76/sh+1,326$46,092→ 6,748 total - Exercise/Conversion
Class A common stock
2023-03-10$27.32/sh+199$5,437→ 5,422 total - Exercise/Conversion
Class A common stock
2023-03-10$34.76/sh+4,215$146,513→ 10,963 total - Sale
Class A common stock
2023-03-10$83.73/sh−5,740$480,610→ 5,223 total - Exercise/Conversion
Stock Option (right to buy)
2023-03-10−199→ 0 totalExercise: $27.32Exp: 2032-01-03→ Class A common stock (199 underlying) - Exercise/Conversion
Stock Option (right-to-buy)
2023-03-10−1,326→ 443 totalExercise: $34.76Exp: 2032-06-08→ Class A common stock (1,326 underlying) - Exercise/Conversion
Stock Option (right-to-buy)
2023-03-10−4,215→ 1,405 totalExercise: $34.76Exp: 2032-06-08→ Class A common stock (4,215 underlying)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $83.67 to $83.86. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The options vested in two equal installments on March 10, 2022 and June 10, 2022.
- [F3]The options vest in four equal installments on September 14, 2022, December 8, 2022, March 1, 2023, and June 7, 2023, subject to continued service through each vesting date.
Documents
Issuer
REATA PHARMACEUTICALS INC
CIK 0001358762
Entity typeother
Related Parties
1- filerCIK 0001685986
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 5:23 PM ET
- Size
- 16.4 KB